Video content above is prompted by the following:
- How do you decide between different treatment approaches, such as bispecific antibodies (BCMA/GPRC5D), CAR T-cell therapy or other targeted treatments?
- What are the differences in effectiveness, side effects and accessibility between these therapies?
